101 related articles for article (PubMed ID: 31414914)
1. Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial.
Abdel-Rahman O
Expert Rev Respir Med; 2019 Oct; 13(10):1029-1035. PubMed ID: 31414914
[No Abstract] [Full Text] [Related]
2. Prediagnostic BMI and thyroid cancer incidence in the PLCO trial.
Abdel-Rahman O
Future Oncol; 2019 Oct; 15(30):3451-3456. PubMed ID: 31646903
[No Abstract] [Full Text] [Related]
3. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
[TBL] [Abstract][Full Text] [Related]
4. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
Zheng R; Du M; Zhang B; Xin J; Chu H; Ni M; Zhang Z; Gu D; Wang M
Br J Cancer; 2018 Jul; 119(1):130-132. PubMed ID: 29872147
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults : BMI change and the risks of colorectal cancer incidence and mortality.
Li JB; Luo S; Wong MCS; Li C; Feng LF; Peng JH; Li JH; Zhang X
BMC Cancer; 2019 Nov; 19(1):1082. PubMed ID: 31711465
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams.
Kroenke CH; Neugebauer R; Meyerhardt J; Prado CM; Weltzien E; Kwan ML; Xiao J; Caan BJ
JAMA Oncol; 2016 Sep; 2(9):1137-45. PubMed ID: 27196302
[TBL] [Abstract][Full Text] [Related]
8. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
Petrick JL; Kelly SP; Liao LM; Freedman ND; Graubard BI; Cook MB
Br J Cancer; 2017 Mar; 116(7):951-959. PubMed ID: 28196067
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
10. Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysis.
Gupta A; Majumder K; Arora N; Mayo HG; Singh PP; Beg MS; Hughes R; Singh S; Johnson DH
Lung Cancer; 2016 Dec; 102():49-59. PubMed ID: 27987589
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial.
Luo L; Liu Y; Wang Z; Yan Y; Xie C; Chi J; Yang Y; Li J; Xu R
Ann Transl Med; 2020 Jul; 8(13):815. PubMed ID: 32793660
[TBL] [Abstract][Full Text] [Related]
12. Associations of genetic risk, BMI trajectories, and the risk of non-small cell lung cancer: a population-based cohort study.
You D; Wang D; Wu Y; Chen X; Shao F; Wei Y; Zhang R; Lange T; Ma H; Xu H; Hu Z; Christiani DC; Shen H; Chen F; Zhao Y
BMC Med; 2022 Jun; 20(1):203. PubMed ID: 35658861
[TBL] [Abstract][Full Text] [Related]
13. [Body mass index and the risk of lung cancer incidence in smokers: a prospective cohort study].
Li F; Xie SH; Wang G; Su K; Feng XS; Lyu ZY; Guo LW; Chen SH; Chang S; Chen YH; Ren JS; Shi JF; Yang WJ; Cui H; Wu SL; Dai M; Li N; He J
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 May; 50(5):385-90. PubMed ID: 27141892
[TBL] [Abstract][Full Text] [Related]
14. Body mass index in young adulthood, obesity trajectory, and premature mortality.
Hirko KA; Kantor ED; Cohen SS; Blot WJ; Stampfer MJ; Signorello LB
Am J Epidemiol; 2015 Sep; 182(5):441-50. PubMed ID: 25977515
[TBL] [Abstract][Full Text] [Related]
15. Association of obesity with cardiovascular disease mortality in the PLCO trial.
Jiang J; Ahn J; Huang WY; Hayes RB
Prev Med; 2013 Jul; 57(1):60-4. PubMed ID: 23632233
[TBL] [Abstract][Full Text] [Related]
16. Variability of body mass index and risks of prostate, lung, colon, and ovarian cancers.
Sun Y; Zhou L; Shan T; Ouyang Q; Li X; Fan Y; Li Y; Gong H; Alolga RN; Ma G; Ge Y; Zhang H
Front Public Health; 2022; 10():937877. PubMed ID: 36091512
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hoyt M; Song Y; Gao S; O'Palka J; Zhang J
Obesity (Silver Spring); 2022 Nov; 30(11):2275-2285. PubMed ID: 36156459
[TBL] [Abstract][Full Text] [Related]
18. Pre-diagnostic changes in body mass index and mortality among breast cancer patients.
Larsen SB; Torstensson M; Kenborg L; Christensen J; Kroman N; Dalton SO; Tjønneland A; Johansen C; Bidstrup PE
Breast Cancer Res Treat; 2018 Aug; 170(3):605-612. PubMed ID: 29637418
[TBL] [Abstract][Full Text] [Related]
19. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis.
Schlesinger S; Siegert S; Koch M; Walter J; Heits N; Hinz S; Jacobs G; Hampe J; Schafmayer C; Nöthlings U
Cancer Causes Control; 2014 Oct; 25(10):1407-18. PubMed ID: 25037235
[TBL] [Abstract][Full Text] [Related]
20. [Association between body mass index and risk of lung cancer in non-smoking males: a prospective cohort study].
Xie SH; Wang G; Guo LW; Chen SH; Su K; Li F; Chang S; Feng XS; Lyu ZY; Chen YH; Ren JS; Yin J; Cui H; Wu SL; Dai M; Li N; He J
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1213-1219. PubMed ID: 27655565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
